Els Monsaert

456 total citations
17 papers, 228 citations indexed

About

Els Monsaert is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Els Monsaert has authored 17 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Els Monsaert's work include Pancreatic and Hepatic Oncology Research (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Colorectal Cancer Surgical Treatments (3 papers). Els Monsaert is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Neuroendocrine Tumor Research Advances (4 papers) and Colorectal Cancer Surgical Treatments (3 papers). Els Monsaert collaborates with scholars based in Belgium, Cambodia and France. Els Monsaert's co-authors include Marc Peeters, Marc Polus, Anne Demols, Alain Hendlisz, Jean‐Luc Van Laethem, Raphaël Maréchal, Fabien Gay, Nele Boeckx, Ken Op de Beeck and Vanessa Deschoolmeester and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Els Monsaert

15 papers receiving 223 citations

Peers

Els Monsaert

ONCOL

PRM

SURGE

EPIDE

Mustafa Karaağaç Türkiye

Filippo Pagani Italy

Kazuto Shibuya Japan

Andrea Barina Italy

Sreelakshmi Mallappa United Kingdom

J. Selleslags Belgium

Irene Pecora Italy

Cristina Morelli Italy

Luca Pompella Italy

Hajime Ushigome Japan

Mustafa Karaağaç Türkiye

Els Monsaert

142 ×0.8

ONCOL

47 ×0.5

69 ×1.1

PRM

55 ×0.9

SURGE

21 ×0.5

EPIDE

Citations per year, relative to Els Monsaert Els Monsaert (= 1×) peers Mustafa Karaağaç

Countries citing papers authored by Els Monsaert

Since Specialization

Citations

This map shows the geographic impact of Els Monsaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Els Monsaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Els Monsaert more than expected).

Fields of papers citing papers by Els Monsaert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Els Monsaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Els Monsaert. The network helps show where Els Monsaert may publish in the future.

Co-authorship network of co-authors of Els Monsaert

This figure shows the co-authorship network connecting the top 25 collaborators of Els Monsaert. A scholar is included among the top collaborators of Els Monsaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Els Monsaert. Els Monsaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Defoort, Barbara, et al.. (2023). The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report. SHILAP Revista de lepidopterología. 16(1). 453–460.

Monsaert, Els, et al.. (2022). Gemcitabine-induced thrombotic microangiopathy treated with eculizumab: a case report. Journal of Gastrointestinal Oncology. 13(6). 3314–3320. 3 indexed citations

Cocker, Laurens J.L. De, et al.. (2022). Esophageal carcinoma as a portal of entry for brainstem abscess formation. Acta Gastro Enterologica Belgica. 85(1). 105–107.

Monsaert, Els, et al.. (2020). Resolution of a hepatoduodenal fistula after nivolumab treatment in a patient with hepatocellular carcinoma: challenges in immunotherapy. Acta Clinica Belgica. 77(1). 108–112. 3 indexed citations

Boeckx, Nele, Ken Op de Beeck, Matthias Beyens, et al.. (2018). Mutation and Methylation Analysis of Circulating Tumor DNA Can Be Used for Follow-up of Metastatic Colorectal Cancer Patients. Clinical Colorectal Cancer. 17(2). e369–e379. 39 indexed citations

Piessevaux, Hubert, Wim Demey, Alain Bols, et al.. (2018). Effect of oral magnesium supplementation on the kinetics of magnesium wasting induced by EGFR targeted antibody therapy for colorectal carcinoma (MAGNET trial). Annals of Oncology. 29. viii640–viii640. 1 indexed citations

Decoster, Lore, Cindy Kenis, Marc De Man, et al.. (2017). Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: Results of a prospective observational cohort study (AVAPLUS). Journal of Geriatric Oncology. 9(2). 93–101. 14 indexed citations

Cutsem, Eric Van, Lore Decoster, Marc De Man, et al.. (2016). PD-030 Prospective non-interventional study to collect data on the use of bevacizumab and conventional chemotherapy for the treatment of previously untreated metastatic colorectal cancer in patient's ≥70 years. Annals of Oncology. 27. ii113–ii113. 1 indexed citations

Heuvel, Bert van den, Marc Peeters, Alain Hendlisz, et al.. (2016). Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept.. PubMed. 3 indexed citations

10.

Kyle-Leinhase, I., et al.. (2015). Retrospective observational study on the incidence of incisional hernias after reversal of a temporary diverting ileostomy following rectal carcinoma resection with follow-up CT scans. Hernia. 20(2). 271–277. 22 indexed citations

11.

Hulstaert, Eva, et al.. (2015). Ischaemic necrosis of the tongue as a rare complication of cardiogenic shock. Acta Clinica Belgica. 70(6). 436–439. 1 indexed citations

12.

Hulstaert, Eva, et al.. (2015). Ischaemic necrosis of the tongue as a rare complication of cardiogenic shock. Acta Clinica Belgica. 70(6). 436–439. 5 indexed citations

13.

Pletinckx, Pieter, et al.. (2014). Intermittent adult ileocecal intussusception: a case report and review of literature. Acta Clinica Belgica. 69(1). 76–81. 5 indexed citations

14.

Hav, Monirath, Frederik Berrevoet, Roberto Troisi, et al.. (2013). Cisplatin-Modified De Gramont in Second-Line Therapy for Pancreatic Adenocarcinoma. Pancreas. 42(7). 1138–1142. 2 indexed citations

15.

Laurent, Stéphanie, Els Monsaert, Tom Boterberg, et al.. (2009). Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I–II study. Annals of Oncology. 20(8). 1369–1374. 14 indexed citations

16.

Demols, Anne, Marc Peeters, Marc Polus, et al.. (2006). Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. British Journal of Cancer. 94(4). 481–485. 107 indexed citations

17.

Ceelen, Wim, Tom Boterberg, Piet Pattyn, et al.. (2006). Neoadjuvant Chemoradiation Versus Hyperfractionated Accelerated Radiotherapy in Locally Advanced Rectal Cancer. Annals of Surgical Oncology. 14(2). 424–431. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact